Skip to content
healthcare.dev

Entecavir

NDC 65162-449, Entecavir, tablet, film coated, from Amneal Pharmaceuticals LLC.

Product NDC
65162-449
Status
Listed
Labeler
Amneal Pharmaceuticals LLC
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206652
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65162-449 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ENTECAVIR1 mg/1

Pharmacologic classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Analog [EXT]; Nucleoside Reverse Transcriptase Inhibitors [MoA]

Package NDCNDC-11Package
65162-449-036516204490330 TABLET, FILM COATED in 1 BOTTLE (65162-449-03)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/007a6ad8-4d23-4543-ae48-c651cac7dd7b

Use it

Look up 65162-449 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65162-449 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65162-449. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.